These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 35918354)

  • 1. Construction of a novel signature and prediction of the immune landscape in gastric cancer based on necroptosis-related genes.
    Li Z; Yang W; Liu D; Ye W; Du G; Li X
    Sci Rep; 2022 Aug; 12(1):13290. PubMed ID: 35918354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
    Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
    Front Immunol; 2022; 13():968165. PubMed ID: 36389725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma.
    Peng YL; Wang LX; Li MY; Liu LP; Li RS
    PLoS One; 2023; 18(2):e0279744. PubMed ID: 36795724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
    Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
    BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Profiling Reveals Prognostic and Immunogenic Characteristics of Necroptosis in Soft Tissue Sarcomas.
    Qi L; Xu R; Ren X; Zhang W; Yang Z; Tu C; Li Z
    Front Immunol; 2022; 13():877815. PubMed ID: 35663937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A necroptosis-related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma.
    Chen J; Wang H; Zhou L; Liu Z; Chen H; Tan X
    Cancer Med; 2022 Dec; 11(24):5079-5096. PubMed ID: 35560794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Validation a Necroptosis-Related Prognostic Signature in Cervical Cancer.
    Yang Z; Li J; Tang Y; Zou L
    Reprod Sci; 2023 Jun; 30(6):2003-2015. PubMed ID: 36576713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Prognostic Model for Esophageal Adenocarcinoma Based on Necroptosis-Related Genes.
    Zhang S; Liu S; Lin Z; Zhang J; Lin Z; Fang H; Hu Z
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
    Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
    Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma.
    Xu L; Gao X; Xing J; Guo Z
    Front Immunol; 2023; 14():1118816. PubMed ID: 36936916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyroptosis, apoptosis, and necroptosis molecular subtype derived prognostic signature universal applicable for gastric cancer-A large sample and multicenter retrospective analysis.
    Huo J; Xie W; Fan X; Sun P
    Comput Biol Med; 2022 Oct; 149():106037. PubMed ID: 36044785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer.
    Pu S; Zhou Y; Xie P; Gao X; Liu Y; Ren Y; He J; Hao N
    Front Immunol; 2022; 13():964118. PubMed ID: 36059470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine learning-based signature of necrosis-associated lncRNAs for prognostic and immunotherapy response prediction in cutaneous melanoma and tumor immune landscape characterization.
    Cui Z; Liang Z; Song B; Zhu Y; Chen G; Gu Y; Liang B; Ma J; Song B
    Front Endocrinol (Lausanne); 2023; 14():1180732. PubMed ID: 37229449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Necroptosis-related Molecular Subtypes and Construction of Necroptosis-related Gene Signature for Glioblastoma Multiforme.
    Li Z; Jin Y; Que T; Zhang XA; Yi G; Zheng H; Yuan X; Wang X; Xu H; Nan J; Chen C; Wu Y; Huang G
    Curr Med Chem; 2024; 31(33):5417-5431. PubMed ID: 37539935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering a Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Clear Cell Renal Carcinoma.
    Bao JH; Li JB; Lin HS; Zhang WJ; Guo BY; Li JJ; Fu LM; Sun YP
    Anal Cell Pathol (Amst); 2022; 2022():2721005. PubMed ID: 35509814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel necroptosis-related gene signature associated with immune landscape for predicting the prognosis of papillary thyroid cancer.
    Wang Z; Wu P; Shi J; Ji X; He L; Dong W; Wang Z; Zhang H; Sun W
    Front Genet; 2022; 13():947216. PubMed ID: 36186479
    [No Abstract]   [Full Text] [Related]  

  • 18. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
    Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y
    Front Immunol; 2022; 13():977338. PubMed ID: 36159818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
    Xie Y; Xu Z; Mei X; Shi W
    Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive pan-cancer analysis of necroptosis molecules in four gynecologic cancers.
    Zheng J; Cai X; Zhang Y; Wang H; Liu L; Tang F; Liu L; Sun Y
    BMC Cancer; 2022 Nov; 22(1):1160. PubMed ID: 36357839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.